Retreating chronic hepatitis C with dail
✍
Bruce R. Bacon; Mitchell L. Shiffman; Flavia Mendes; Reem Ghalib; Tarek Hassanei
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 244 KB
👁 1 views
Up to 50% of patients with chronic hepatitis C fail to respond to initial therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV). With unsuccessful viral eradication, these patients remain at risk for developing progression of their liver disease. Retreatment with PEG-IFN/RBV yields sustain